Table 4 Cardiovascular drugs in groups of patients according to ABG analysis values and in the entire cohort
| Mixed respiratory acidosis – metabolic alkalosis (N = 36) | Compensated respiratory acidosis (N = 51) | Mixed respiratory - metabolic acidosis (N = 23) | Hypercapnic COPD, entire cohort (N = 110) | |
|---|---|---|---|---|
| Diuretics | 33/36 | 40/51 | 22/23 | 95/110 |
| ACE inhibitors | 9/36 | 14/50 | 3/20 | 26/106 |
| Angiotensin receptor antagonists | 12/36 | 15/50 | 4/20 | 31/106 |
| Calcium channel blocking agents | 5/36 | 15/50 | 3/20 | 23/106 |
| Beta-blockers | 3/36 | 4/50 | 0/20 | 7/106 |
| Nitroglycerin | 7/36 | 3/50 | 1/20 | 11/106 |
| Potassium sparing agents | 4/36 | 3/50 | 1/21 | 8/107 |